These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study. Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866 [TBL] [Abstract][Full Text] [Related]
14. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures. Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081 [TBL] [Abstract][Full Text] [Related]
15. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience. Hwee YK; Park D; Vinas M; Litts C; Friedman D Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture. McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625 [TBL] [Abstract][Full Text] [Related]